Calamos Advisors LLC Sells 12,723 Shares of Procter & Gamble Company (The) $PG

Calamos Advisors LLC lowered its position in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 2.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 481,445 shares of the company’s stock after selling 12,723 shares during the period. Calamos Advisors LLC’s holdings in Procter & Gamble were worth $68,996,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Assenagon Asset Management S.A. increased its stake in Procter & Gamble by 100.8% in the 4th quarter. Assenagon Asset Management S.A. now owns 5,460,939 shares of the company’s stock worth $782,607,000 after acquiring an additional 2,741,924 shares during the last quarter. Amundi boosted its position in shares of Procter & Gamble by 26.3% during the 3rd quarter. Amundi now owns 10,682,455 shares of the company’s stock valued at $1,606,748,000 after acquiring an additional 2,222,560 shares during the last quarter. Franklin Resources Inc. grew its holdings in shares of Procter & Gamble by 8.3% during the third quarter. Franklin Resources Inc. now owns 22,850,345 shares of the company’s stock worth $3,510,955,000 after purchasing an additional 1,752,481 shares in the last quarter. Danske Bank A S purchased a new position in shares of Procter & Gamble during the third quarter worth about $252,853,000. Finally, Vanguard Group Inc. increased its position in shares of Procter & Gamble by 0.6% in the third quarter. Vanguard Group Inc. now owns 234,630,605 shares of the company’s stock worth $36,050,992,000 after purchasing an additional 1,419,322 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

PG stock opened at $148.11 on Friday. The firm has a market cap of $344.21 billion, a P/E ratio of 21.94, a P/E/G ratio of 5.62 and a beta of 0.41. The firm’s fifty day moving average is $150.32 and its 200 day moving average is $148.70. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $170.99. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Friday, April 24th. The company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.56 by $0.03. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The business had revenue of $21.24 billion during the quarter, compared to the consensus estimate of $21.52 billion. During the same period in the previous year, the firm posted $1.54 earnings per share. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts predict that Procter & Gamble Company will post 6.95 earnings per share for the current year.

Procter & Gamble Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 24th will be paid a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.9%. This is a boost from Procter & Gamble’s previous quarterly dividend of $1.06. The ex-dividend date of this dividend is Friday, April 24th. Procter & Gamble’s payout ratio is currently 62.67%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on PG shares. Deutsche Bank Aktiengesellschaft cut their price target on shares of Procter & Gamble from $171.00 to $162.00 and set a “hold” rating for the company in a research note on Monday, March 30th. BNP Paribas Exane cut their target price on shares of Procter & Gamble from $172.00 to $165.00 and set an “outperform” rating for the company in a research report on Thursday. Piper Sandler reduced their target price on Procter & Gamble from $150.00 to $142.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 8th. TD Cowen lowered their price target on Procter & Gamble from $156.00 to $142.00 and set a “hold” rating on the stock in a research report on Wednesday, April 1st. Finally, Royal Bank Of Canada cut their price objective on Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating for the company in a report on Thursday, April 9th. Ten investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.

Check Out Our Latest Report on PG

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Q3 earnings and core metrics beat expectations — adjusted EPS topped consensus and net sales/organic sales rose year‑over‑year, showing volume-led growth that suggests improving consumer demand. Business Wire: Q3 Results
  • Positive Sentiment: Beauty and premium brands outperformed (e.g., SK‑II growth), supporting higher-margin mix and contributing to market‑share gains cited by management. Reuters: Beauty Demand Strength
  • Positive Sentiment: Unusually heavy call-option buying and positive analyst notes pre/post‑release amplified buying momentum, signaling increased bullish positioning from traders and some brokers. (Options volume spike reported in market coverage.)
  • Neutral Sentiment: Management reiterated fiscal‑2026 guidance (EPS range ~6.83–7.09) and maintained its outlook — that gives reassurance on the plan but leaves upside capped until guidance is raised. P&G Press Release / Slides
  • Negative Sentiment: P&G disclosed a roughly $150 million hit to annual profits from Middle East disruptions (higher energy/logistics/input costs), a tangible near‑term headwind that pressure margins and could constrain FY earnings. Benzinga: $150M Hit
  • Negative Sentiment: Some sell‑side desks trimmed price targets and highlighted input-cost risks (resin, energy), which tempers upside and keeps valuation scrutiny on the stock. MarketScreener: PT Adjustments

Insider Transactions at Procter & Gamble

In other news, insider Balaji Purushothaman sold 12,827 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $160.31, for a total transaction of $2,056,296.37. Following the completion of the sale, the insider directly owned 12,639 shares in the company, valued at approximately $2,026,158.09. This represents a 50.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Gary A. Coombe sold 36,093 shares of the firm’s stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $162.33, for a total value of $5,858,976.69. Following the completion of the sale, the chief executive officer directly owned 34,994 shares in the company, valued at $5,680,576.02. The trade was a 50.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 252,715 shares of company stock valued at $40,966,904. 0.20% of the stock is currently owned by insiders.

About Procter & Gamble

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.